From: Proceedings of the 28th European Paediatric Rheumatology Congress (PReS 2022)
Factors | Mean (SD) | CV | Factors | Mean (SD) | CV |
---|---|---|---|---|---|
Number of swollen joints | 86.8 (18.6) | 21.0 | Functional ability | 53.2 (31.7) | 59.6 |
Number of tender joints | 74.4 (24.6) | 33.0 | Parent/patient pain VAS | 48.9 (31.3) | 64.2 |
Duration of morning stiffness | 64.0(28.4) | 44.7 | Psoriatic skin manifestations | 48.7 (31.9) | 65.5 |
Presence of active uveitis | 67.5 (31.1) | 46.1 | Parent/patient global VAS | 46.9 (31.6) | 67.5 |
Number of restricted joints | 63.6 (30.0) | 47.1 | Presence of erosions | 52.8 (35.6) | 67.5 |
Dactylitis | 63.9 (29.4) | 47.2 | Proportion of large vs small active joints | 46.1 (31.2) | 67.7 |
Laboratory findings | 59.5 (29.3) | 49.8 | Presence of fever | 46.5 (37.2) | 80.0 |
Degree of inflammation in the active joints valued by US | 59.9 (32.7) | 54.6 | Other factors | 13.3 (29.2) | 218.7 |
Degree of inflammation in the active joints valued by MRI | 60.8 (33.4) | 55.0 | Â | Â | Â |